Liver Steatosis Measurement
Liver Steatosis Measurement - Related Videos
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
0 Views •
Cited by 28 •
2017
Here, optimized methods to generate in vivo and in vitro models of hepatic steatosis and to analyze the steatotic phenotypes and related physiological parameters are described.
02:44
Oil Red O Staining: A Technique for Staining Neutral Lipids in Hepatocytes for Detecting Hepatic Steatosis In Vitro
0 Views •
2025
In this video, we demonstrate in vitro staining of neutral lipids in hepatocytes to detect hepatic steatosis or excessive fat accumulation in liver. Excessive fat is accumulated in the cells in form of lipid droplets. Oil Red O is a lipid soluble dye that binds to intracellular neutral lipids in these lipid droplets. When observed under a light microscope, these intracellular lipid droplets appear intensely red in color.
05:56
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
0 Views •
2025
The goal of this protocol is to showcase the technique and use of point-of-care transient elastography for pediatric gastroenterologists monitoring hepatobiliary involvement and advanced cystic fibrosis liver disease in persons with cystic fibrosis.
12:35
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
0 Views •
Cited by 14 •
2011
The study of liver sinusoidal endothelial cells (SECs) must be performed with primary cells obtained from the animal as no cell lines exist. This method relies on liver digestion and differential centrifugation for SEC purification for subsequent culturing and experimentation.
07:27
The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
0 Views •
Cited by 14 •
2017
Here we describe a common method to induce chronic liver injury in mice by feeding of a choline-deficient and ethionine-supplemented (CDE) diet. We demonstrate health monitoring, liver perfusion, isolation, and preservation. A time course of six weeks can inform about liver injury, pathohistology, fibrosis, inflammatory, and liver progenitor cell responses.
FAQs
No single readout captures every aspect of lipid accumulation. Histological methods show how fat is distributed within liver tissue, biochemical analysis measures hepatic lipid content, and imaging detects fat-associated signals. Using complementary approaches helps researchers distinguish changes in tissue pattern from changes in overall lipid amount, producing a more complete comparison among experimental groups.
These stains support tissue-level assessment by revealing structural features associated with lipid accumulation in liver samples. Their value lies in showing where changes occur and how they are arranged within the tissue, rather than only reporting a bulk lipid measurement. This spatial information can help relate steatosis to differences among biological samples or treatment groups.
Biochemical measurement focuses on the amount of lipid present in hepatic tissue, while imaging-based analysis evaluates fat-related signals and histology examines tissue structure and distribution. Because these readouts describe different properties, they can complement one another. Agreement across approaches strengthens interpretation, whereas differences may indicate that amount, location, and detectable signal are not changing identically.
Researchers first select a readout that matches the study question, such as tissue distribution, hepatic lipid content, or an imaging-based fat signal. They then apply the same measurement approach across the relevant groups so results can be compared. This consistency supports evaluation of how genes, diets, drugs, or other interventions influence fatty liver development.
The approach is useful whenever investigators need to evaluate fatty liver changes in relation to metabolism, obesity, toxicology, or liver disease. It can reveal whether an experimental condition is associated with greater or reduced steatosis and provides a basis for comparing biological responses. The selected method determines whether the study emphasizes tissue pattern, lipid amount, or fat-related imaging signals.
Measurements provide comparable outcomes for experimental groups exposed to different genetic conditions, diets, drugs, or other interventions. Researchers can examine tissue appearance, hepatic lipid content, or imaging signals to determine whether steatosis changes between groups. These results connect an intervention with fatty liver development and support broader studies of metabolic biology, toxicology, and liver disease.